Home/Filings/4/0000805928-25-000165
4//SEC Filing

DeVinney Erick Wayne 4

Accession 0000805928-25-000165

CIK 0000805928other

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:20 PM ET

Size

5.6 KB

Accession

0000805928-25-000165

Insider Transaction Report

Form 4
Period: 2025-12-09
DeVinney Erick Wayne
VP of Clin. & Trans. Sciences
Transactions
  • Sale

    Common Stock

    2025-12-09$31.21/sh19,517$609,087241,132 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units on December 4, 2025. This sale does not represent a discretionary trade by the Reporting Person.
  • [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold on December 9, 2025, in multiple transactions at $31.208 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001595972

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:20 PM ET
Size
5.6 KB